Should I Buy GHC? GHC 2026 Analysis

Should You Buy Graham Holdings Co (GHC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

1158.230

1 Day change

-2.26%

52 Week Range

1224.760

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now for a tactical entry: price (~1160 pre-market) is sitting below the pivot (1176.8) and closer to support (1144.8), which sets up a reasonable bounce/reversion target back toward 1177–1209.
The broader trend is still constructive (SMA_5 > SMA_20 > SMA_200), so dips are more attractive than chasing strength.
Fundamental momentum is strong (2025/Q3 EPS and net income surged YoY), which supports buying despite the lack of near-term news.
Near-term risk is that momentum is currently weakening (MACD histogram negative and expanding), so the trade thesis is more “buy the dip in an uptrend” than “buy a breakout.”

Technical Analysis

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.
Trend/MAs: Bullish structure with SMA_5 > SMA_20 > SMA_200, implying the primary trend remains up.
Momentum: MACD histogram at -1.593 and negatively expanding = bearish/weakening momentum in the short term.
RSI: RSI_6 ~49.4 (neutral), suggesting no exhaustion; room for either direction.
Key levels: Pivot 1176.8 (near-term magnet). Support S1 1144.8 then 1125.1. Resistance R1 1208.8 then 1228.6.
Practical read: With price ~1160 pre-market (below pivot), the nearer setup is a bounce attempt toward 1177, then 1209 if momentum improves.

Positive Catalysts

supports buying pullbacks.

Neutral/Negative Catalysts

- MACD momentum is bearish and deteriorating (negative histogram expanding), which can keep the stock capped near resistance.
- Gross margin declined in 2025/Q3 (down ~7% YoY), indicating margin pressure.
- No news flow in the last week, limiting immediate catalyst support.
- No notable hedge fund/insider trend signals recently (both described as neutral).

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: $1.279B, +5.94% YoY (steady top-line growth).
Net income: $122.2M, +69.68% YoY (strong acceleration in profitability).
EPS: 27.91, +69.98% YoY (major earnings leverage).
Gross margin: 27.01%, -7.02% YoY (the main soft spot: margin compression despite earnings growth).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so the current Wall Street stance cannot be confirmed from this dataset.
Pros (typical of what would support bullish coverage): strong YoY EPS/net income growth and an intact longer-term uptrend.
Cons (typical of what would temper coverage): margin compression and currently weakening momentum indicators.

Analyst Rating

Wall Street analysts forecast GHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GHC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1185.050

Low

Averages

High